| Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma MC Kyrtsonis, TP Vassilakopoulos, N Kafasi, S Sachanas, T Tzenou, ... British journal of haematology 137 (3), 240-243, 2007 | 202 | 2007 |
| B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenström's macroglobulinemia: a clinical, morphologic, and biologic … GA Pangalis, MK Angelopoulou, TP Vassilakopoulos, MP Siakantaris, ... Seminars in hematology 36 (2), 104-114, 1999 | 139 | 1999 |
| Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care TP Vassilakopoulos, GA Pangalis, A Katsigiannis, SG Papageorgiou, ... The oncologist 17 (2), 239-249, 2012 | 135 | 2012 |
| Rituximab monotherapy is highly effective in splenic marginal zone lymphoma C Kalpadakis, GA Pangalis, MN Dimopoulou, TP Vassilakopoulos, ... Hematological oncology 25 (3), 127-131, 2007 | 119 | 2007 |
| Pulmonary Balantidium coli infection in a leukemic patient K Anargyrou, GL Petrikkos, MTE Suller, A Skiada, MP Siakantaris, ... American Journal of hematology 73 (3), 180-183, 2003 | 107 | 2003 |
| Treatment of splenic marginal zone lymphoma with rituximab monotherapy: progress report and comparison with splenectomy C Kalpadakis, GA Pangalis, MK Angelopoulou, S Sachanas, ... The Oncologist 18 (2), 190-197, 2013 | 100 | 2013 |
| Waldenström's macroglobulinemia: clinical course and prognostic factors in 60 patients: Experience from a single hematology unit MC Kyrtsonis, T Vassilakopoulos, M Angelopoulou, M Siakantaris, ... Annals of hematology 80, 722-727, 2001 | 99 | 2001 |
| Campath-1H (anti-CD52) monoclonal antibody therapy in lymphoproliferative disorders: A review GA Pangalis, MN Dimopoulou, MK Angelopoulou, C Tsekouras, ... Medical Oncology 18, 99-107, 2001 | 90 | 2001 |
| Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphoma TP Vassilakopoulos, G Nadali, MK Angelopoulou, MP Siakantaris, ... haematologica 86 (3), 274-281, 2001 | 89 | 2001 |
| Angiogenesis in Hodgkin's lymphoma: a morphometric approach in 286 patients with prognostic implications P Korkolopoulou, I Thymara, N Kavantzas, TP Vassilakopoulos, ... Leukemia 19 (6), 894-900, 2005 | 83 | 2005 |
| B‐chronic lymphocytic leukemia: practical aspects GA Pangalis, TP Vassilakopoulos, MN Dimopoulou, MP Siakantaris, ... Hematological oncology 20 (3), 103-146, 2002 | 82 | 2002 |
| Development and validation of a clinical prediction rule for bone marrow involvement in patients with Hodgkin lymphoma TP Vassilakopoulos, MK Angelopoulou, N Constantinou, T Karmiris, ... Blood 105 (5), 1875-1880, 2005 | 76 | 2005 |
| The prognostic significance of beta (2)-microglobulin in patients with Hodgkin's lymphoma TP Vassilakopoulos, G Nadali, MK Angelopoulou, MP Siakantaris, ... haematologica 87 (7), 701-708, 2002 | 69 | 2002 |
| Effective treatment of disease‐related anaemia in B‐chronic lymphocytic leukaemia patients with recombinant human erythropoietin GA Pangalis, C Poziopoulos, MK Angelopoulou, MP Siakantaris, ... British journal of haematology 89 (3), 627-629, 1995 | 55 | 1995 |
| PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent … TP Vassilakopoulos, GA Pangalis, S Chatziioannou, S Papageorgiou, ... Leukemia 30 (1), 238-242, 2016 | 52 | 2016 |
| Serum syndecan‐1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease MC Kyrtsonis, TP Vassilakopoulos, MP Siakantaris, SI Kokoris, ... European journal of haematology 72 (4), 252-258, 2004 | 52 | 2004 |
| Prognostic factors in advanced stage Hodgkin's lymphoma: the significance of the number of involved anatomic sites TP Vassilakopoulos, MK Angelopoulou, MP Siakantaris, FN Kontopidou, ... European journal of haematology 67 (5‐6), 279-288, 2001 | 52 | 2001 |
| Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance C Kalpadakis, GA Pangalis, S Sachanas, P Tsirkinidis, FN Kontopidou, ... Blood, The Journal of the American Society of Hematology 132 (6), 666-670, 2018 | 49 | 2018 |
| Favorable outcome of primary cutaneous marginal zone lymphoma treated with intralesional rituximab MC Kyrtsonis, MP Siakantaris, C Kalpadakis, MN Dimopoulou, ... European journal of haematology 77 (4), 300-303, 2006 | 48 | 2006 |
| Combination of rituximab with chlorambucil as first line treatment in patients with mantle cell lymphoma: a highly effective regimen S Sachanas, GA Pangalis, TP Vassilakopoulos, P Korkolopoulou, ... Leukemia & lymphoma 52 (3), 387-393, 2011 | 47 | 2011 |
